Stocks News

LAST PRICE
176.7900
TODAY'S CHANGE (%)
Trending Down-1.7600 (-0.9857%)

Bid / Lots
170.8200/ 1
Ask / Lots
182.6300/ 1
Open / Previous Close
179.3500 / 178.5500
Day Range
Low 176.4400
High 179.6550
52 Week Range
Low 78.2800
High 188.5300
Volume
258,176
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 6, 2024
- ICU Medical to Participate at the UBS Global Healthcare Conference, from 8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: ICUI
  
  ICU Medical to Participate at the UBS Global Healthcare Conference
  
  SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical's presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, November 13, 2024.
Nov 5, 2024
- ICU Medical Insider Sold Shares Worth $2,062,136, According to a Recent SEC Filing, from 3:28AM ET on Tuesday Nov 05, 2024 by MT Newswires
  3:28AM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: ICUI
  03:28 AM EST, 11/05/2024 (MT Newswires) -- Vivek Jain, Director, Chairman and Chief Executive Officer, on November 01, 2024, sold 12,000 shares in ICU Medical (ICUI) for $2,062,136. Following the Form 4 filing with the SEC, Jain has control over a t...
Oct 28, 2024
- ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call, from 8:30AM ET on Monday Oct 28, 2024 by Dow Jones
  8:30AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: ICUI
  
  ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call
  
  SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call.
Oct 15, 2024
- DJ ICU Medical Is Maintained at Overweight by Keybanc, from 8:01AM ET on Tuesday Oct 15, 2024 by Dow Jones
  8:01AM ET on Tuesday Oct 15, 2024 by Dow Jones
  Companies Mentioned: ICUI
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ICUI/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 15, 2024 08:01 ET (12:01 GMT)
Oct 14, 2024
- DJ ICU Medical Initiated at Hold by Jefferies, from 8:51AM ET on Monday Oct 14, 2024 by Dow Jones
  8:51AM ET on Monday Oct 14, 2024 by Dow Jones
  Companies Mentioned: ICUI
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ICUI/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 14, 2024 08:51 ET (12:51 GMT)

Yesterday
- DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 18 hours ago by Dow Jones
  18 hours ago by Dow Jones
  Companies Mentioned: HAE
- DJ Haemonetics Raised to Strong Buy From Outperform by Raymond James, from 7:04AM ET on Friday Nov 08, 2024 by Dow Jones
  7:04AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: HAE
Nov 7, 2024
- Haemonetics Fiscal Q2 Adjusted Earnings, Revenue Rise, from 8:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  8:53AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: HAE
- Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by PR Newswire
  6:00AM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: HAE
- Press Release: Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: HAE
- Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: HAE
- DJ Enovis Price Target Maintained With a $65.00/Share by Needham, from 5:12AM ET on Thursday Nov 07, 2024 by Dow Jones
  5:12AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ENOV
Nov 6, 2024
- DJ Enovis Shares Rise On Full-Year Outlook Boost, from 2:20PM ET on Wednesday Nov 06, 2024 by Dow Jones
  2:20PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: ENOV
- Enovis' Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2024 Guidance Updated, from 6:57AM ET on Wednesday Nov 06, 2024 by MT Newswires
  6:57AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: ENOV
- -- Earnings Flash (ENOV) ENOVIS CORPORATION Reports Q3 EPS $0.73, from 6:03AM ET on Wednesday Nov 06, 2024 by MT Newswires
  6:03AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: ENOV

ICU Medical Inc
NASDAQ:ICUIUnited States

Search Criteria

Nov 6, 2024

ICU Medical to Participate at the UBS Global Healthcare Conference, from 8:30AM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

ICU Medical Insider Sold Shares Worth $2,062,136, According to a Recent SEC Filing, from 3:28AM ET on Tuesday Nov 05, 2024 by MT Newswires

Oct 28, 2024

ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call, from 8:30AM ET on Monday Oct 28, 2024 by Dow Jones

Oct 15, 2024

DJ ICU Medical Is Maintained at Overweight by Keybanc, from 8:01AM ET on Tuesday Oct 15, 2024 by Dow Jones

Oct 14, 2024

DJ ICU Medical Initiated at Hold by Jefferies, from 8:51AM ET on Monday Oct 14, 2024 by Dow Jones

Peers Headlines

Yesterday

DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 18 hours ago by Dow Jones

DJ Haemonetics Raised to Strong Buy From Outperform by Raymond James, from 7:04AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Haemonetics Fiscal Q2 Adjusted Earnings, Revenue Rise, from 8:53AM ET on Thursday Nov 07, 2024 by MT Newswires

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by PR Newswire

Press Release: Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Enovis Price Target Maintained With a $65.00/Share by Needham, from 5:12AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

DJ Enovis Shares Rise On Full-Year Outlook Boost, from 2:20PM ET on Wednesday Nov 06, 2024 by Dow Jones

Enovis' Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2024 Guidance Updated, from 6:57AM ET on Wednesday Nov 06, 2024 by MT Newswires

-- Earnings Flash (ENOV) ENOVIS CORPORATION Reports Q3 EPS $0.73, from 6:03AM ET on Wednesday Nov 06, 2024 by MT Newswires